why choose us

First received: January 18, 2023

Clinical Trial: Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Study Status: Completed

Recruit Status: RECRUITING

Condition: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Study Type: INTERVENTIONAL


Official Title: Phase III Randomized Trial of Immunotherapy With or Without Consolidative Radiotherapy for Oligometastatic Head and Neck Squamous Cell Carcinoma

Brief Summary: This phase III trial compares pembrolizumab with radiation therapy to pembrolizumab without radiation therapy (standard therapy) given after pembrolizumab plus chemotherapy for the treatment of patients with squamous cell carcinoma of the head and neck that has spread from where it first started (primary site) to other places in the body (metastatic).Pembrolizumab is a type of immunotherapy that stimulates the body's immune system to fight cancer cells.Pembrolizumab targets and blocks a protein called PD-1 on…

Read more